Eli Lil­ly to buy ra­dio­phar­ma com­pa­ny Point Bio­phar­ma for $1.4B as PhI­II read­out looms

On a deal­mak­ing spree, Eli Lil­ly will buy an­oth­er can­cer biotech, this time swoop­ing in for pub­licly trad­ed ra­dio­phar­ma com­pa­ny Point Bio­phar­ma in a cash …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER